IL-33 (interleukin 33)/SST2 (soluble suppression of tumorigenicity 2) axis in hypertension and heart failure

dc.contributor.authorGhali, Rana
dc.contributor.authorAltara, Raffaele
dc.contributor.authorLouch, William Edward
dc.contributor.authorCataliotti, Alessandro
dc.contributor.authorMallat, Ziad
dc.contributor.authorKaplan, Abdullah
dc.contributor.authorZouein, Fouad A.
dc.contributor.authorBooz, George Warren
dc.contributor.departmentPharmacology and Toxicology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:39:33Z
dc.date.available2025-01-24T11:39:33Z
dc.date.issued2018
dc.identifier.doihttps://doi.org/10.1161/HYPERTENSIONAHA.118.11157
dc.identifier.eid2-s2.0-85055603675
dc.identifier.pmid30354724
dc.identifier.urihttp://hdl.handle.net/10938/29275
dc.language.isoen
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofHypertension
dc.sourceScopus
dc.subjectBiomarkers
dc.subjectHeart failure
dc.subjectHumans
dc.subjectHypertension
dc.subjectInterleukin-1 receptor-like 1 protein
dc.subjectInterleukin-33
dc.subjectSignal transduction
dc.subjectInterleukin 33
dc.subjectProtein
dc.subjectSoluble suppression of tumorigenicity 2 protein
dc.subjectUnclassified drug
dc.subjectBiological marker
dc.subjectIl1rl1 protein, human
dc.subjectInterleukin 1 receptor like 1 protein
dc.subjectAortic stenosis
dc.subjectCardiomyopathy
dc.subjectHeart ventricle hypertrophy
dc.subjectHuman
dc.subjectNonhuman
dc.subjectPriority journal
dc.subjectProtein blood level
dc.subjectProtein expression
dc.subjectPulmonary hypertension
dc.subjectReview
dc.subjectBlood
dc.subjectPhysiology
dc.titleIL-33 (interleukin 33)/SST2 (soluble suppression of tumorigenicity 2) axis in hypertension and heart failure
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-8461.pdf
Size:
323.08 KB
Format:
Adobe Portable Document Format